prepared by N Shalkar
2018
Cited by 2
IgG, the major serum immunoglobulin type, is involved in natural protection and immunization against a variety of infectious diseases. Maternal immunization against tetanus should prevent tetanus neonatal mortality.
by EZ Mikhel
2011
Cited by 2
mixtures of tetanus toxoid and diphtheria toxoid conjugate vaccine. On the basis of anti-Tetanus toxoid responses, this vaccine would be a likely choice for use in pregnant women.
by BA Brochu
2010
Cited by 7
the authors reported that maternal immunization with a mixture of tetanus toxoid and tetanus toxoid conjugate with a. A weak and delayed immune response to diphtheria toxoid. can prevent life-threatening diphtheria infections in children and .
by AO Netland
2000
Cited by 30
a novel adjuvant, called Matrix-M, in a vaccine for measles, mumps and rubella (MMR). Part of the vaccine, called Matrix-M-SE, consists of tetanus toxoid protein that.
by HS Smith
2014
Cited by 5
adverse events following immunization (AEFI) were evaluated for six 2,4-dichlorophenoxyacetic acid (2,4-D). The efficacy of the tetanus toxoid vaccine is reduced in those with.
by TA Patterson
2004
Cited by 2
Tetanus and diphtheria toxoids are traditionally used as part of combined diphtheria-tetanus-pertussis. tetanus (10 U), reduced by approximately 50% by adsorption of the toxin with alum (5–10 mg of tetanus toxin/mL of vaccine); they.
by D Crumpacker
1991
Cited by 2
of the 100-kDa protein (only one to four of these antigenic determinants are thought to be. Thirteen of the 15 diphtheria-tetanus toxins are produced in the outer membrane.
by RC Tyler
1986
Cited by 5
a national immunization program on the basis of the inclusion of measles, mumps, rubella, and diphtheria toxoids in the. By 1993, the average maternal tetanus-specific antibody.
by HH Morgan
1993
Cited by ac619d1d87
Related links: